Key Insights

Highlights

Success Rate

94% trial completion (above average)

Published Results

23 trials with published results (17%)

Research Maturity

64 completed trials (48% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

3.0%

4 terminated out of 133 trials

Success Rate

94.1%

+7.6% vs benchmark

Late-Stage Pipeline

10%

13 trials in Phase 3/4

Results Transparency

36%

23 of 64 completed with results

Key Signals

23 with results94% success

Data Visualizations

Phase Distribution

100Total
Not Applicable (60)
Early P 1 (3)
P 1 (11)
P 2 (13)
P 3 (4)
P 4 (9)

Trial Status

Completed64
Unknown26
Recruiting20
Active Not Recruiting11
Not Yet Recruiting6
Terminated4

Trial Success Rate

94.1%

Benchmark: 86.5%

Based on 64 completed trials

Clinical Trials (133)

Showing 20 of 20 trials
NCT04716127Not ApplicableCompleted

A Proximity-incentive Strategy for Cervical Cancer Screening

NCT05108870Phase 1Active Not RecruitingPrimary

TheraT® Vectors (Vaccines) Combined With Chemotherapy to Treat HPV16 Head and Neck Cancers

NCT05491512Phase 2Recruiting

A Study of Reduced Radiation Therapy and Standard-of-Care Chemotherapy in People With HPV-Positive Throat Cancer

NCT05742386Not ApplicableActive Not RecruitingPrimary

Impact of Standing Orders Optimization

NCT06229353TerminatedPrimary

Developing and Evaluating a Novel Approach to Improve HPV Vaccination Coverage Among High-risk, Under-immunized Adults Via the Emergency Department

NCT04645602Early Phase 1RecruitingPrimary

Merck IIT: RRP Pembro and Lenvatinib

NCT03943875Phase 4Completed

GARDASIL 9: 3 Dose vs. 2 Dose With Delayed 3rd Dose

NCT05880797Recruiting

Multidimensional and Multimodal Profiling of Oropharyngeal Carcinoma

NCT06414057RecruitingPrimary

HPV Equity Study: Exploring Cervical Cancer Control in Scotland for Women With Experience of Priority Risks

NCT07471113Not ApplicableCompletedPrimary

Mobile App-Supported HPV and Breast Cancer Awareness Program

NCT05736718Not ApplicableCompletedPrimary

Engaging Clinical Champions to Improve HPV Vaccination

NCT04423679CompletedPrimary

The Selfie Study- Assessing Novel Markers for Cervical Cancer Screening From Self-collected Samples

NCT03729518Not ApplicableActive Not Recruiting

TORS De-Intensification Protocol Version 2.0: Dose and Volume Reduction in the Neck

NCT05495906Phase 4Recruiting

A Study of Reduced Dosing of the Nonavalent HPV Vaccine in Women Living With HIV

NCT05431699Not ApplicableActive Not RecruitingPrimary

Single Visit Clinical Validation of ScreenFire, a Low-cost HPV Test

NCT06786429Phase 4Not Yet Recruiting

Managing Hepatitis B (Hep. B) and Human Papilloma Virus (HPV) Related Cancers and Mental Health.

NCT07336134Not ApplicableRecruiting

PopSci CHW4CervixHealth

NCT06436274Phase 4Active Not RecruitingPrimary

Efficacy of Human Papillomavirus (HPV) Vaccination to Prevent Infection Among Women Living With HIV.

NCT05600283Not ApplicableCompletedPrimary

Patient Self-sampling of HPV to Screen for Cervical Cancer

NCT05744960Not ApplicableActive Not RecruitingPrimary

Impact of Financial Incentives

Scroll to load more

Research Network

Activity Timeline